s6y
Company name or ticker
Search
Skye Bioscience, Inc.
3
Sharp John P: Initial statement of beneficial ownership of securities
Filed
Tuesday, April 28, 2026
Period
Mar 31, 2026
Accession number
0001628280-26-028062
Documents
FORM 3
3
EX-24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header